Lymphoscintigraphy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head and Neck Cancer
Condition:   Head and Neck Squamous Cell Carcinoma Interventions:   Procedure: Computed Tomography;   Procedure: Lymphoscintigraphy;   Drug: Panitumumab-IRDye800;   Other: Pharmacological Study;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc 99m-labeled Tilmanocept Sponsors:   Eben Rosenthal;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2018 Category: Research Source Type: clinical trials

Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy
Condition:   LymphedemaIntervention:   Procedure: lymphangiographySponsor:   Seoul National University HospitalEnrolling by invitation - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 3, 2015 Category: Research Source Type: clinical trials